American Journal of Ophthalmology
Volume 141, Issue 6 , Pages 1068-1077.e2 , June 2006

Ophthalmologic Findings and Long-Term Course in Patients With Neurofibromatosis Type 2

  • Martina M. Bosch, MD

      Affiliations

    • Department of Ophthalmology, University Hospital Zürich, Zürich, Switzerland
    • ,
  • Eugen Boltshauser, MD

      Affiliations

    • Department of Neurology, University Children’s Hospital Zürich, Zürich, Switzerland
    • ,
  • Paul Harpes, PhD

      Affiliations

    • Department of Biostatistics, University of Zürich, Zürich, Switzerland
    • ,
  • Klara Landau, MD

      Affiliations

    • Department of Ophthalmology, University Hospital Zürich, Zürich, Switzerland
    • Corresponding Author InformationInquiries to Klara Landau, MD, Department of Ophthalmology, University Hospital Zürich, Frauenklinikstrasse 24, 8091 Zürich, Switzerland

,Accepted 28 December 2005.

References 

  1. Parry DM , Eldridge R , Kaiser-Kupfer MI , Bouzas EA , Pikus A , Patronas N . Neurofibromatosis 2 (NF2) (clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity) . Am J Med Genet . 1994;52:450–461
  2. Evans DG , Huson SM , Donnai D , et al.   A clinical study of type 2 neurofibromatosis . Q J Med . 1992;84:603–618
  3. Evans DG , Huson SM , Donnai D , et al.   A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity . J Med Genet . 1992;29:841–846
  4. Gardner W , Frazier C . Bilateral acoustic neurofibromatosis (a clinical study and field survey of a family of five generations with bilateral deafness in thirty-eight members) . Arch Neurol Psychiatry . 1930;23:266–302
  5. Kanter WR , Eldridge R , Fabricant R , Allen JC , Koerber T . Central neurofibromatosis with bilateral acoustic neuroma (genetic, clinical and biochemical distinctions from peripheral neurofibromatosis) . Neurology . 1980;30:851–859
  6. Trofatter JA , MacCollin MM , Rutter JL , et al.   A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor . Cell . 1993;72:791–800
  7. Rouleau GA , Merel P , Lutchman M , et al.   Alteration in a new gene encoding a putative membrane-organizing protein causes neurofibromatosis type 2 . Nature . 1993;363:515–521
  8. Kaiser-Kupfer MI , Freidlin V , Datiles MB , et al.   The association of posterior capsular lens opacities with bilateral acoustic neuromas in patients with neurofibromatosis type 2 . Arch Ophthalmol . 1989;107:541–544
  9. Bouzas EA , Freidlin V , Parry DM , Eldridge R , Kaiser-Kupfer MI . Lens opacities in neurofibromatosis 2 (further significant correlations) . Br J Ophthalmol . 1993;77:354–357
  10. Kaye LD , Rothner AD , Beauchamp GR , Meyers SM , Estes ML . Ocular findings associated with neurofibromatosis type II . Ophthalmology . 1992;99:1424–1429
  11. Landau K , Dossetor FM , Hoyt WF , Muci-Mendoza R . Retinal hamartoma in neurofibromatosis 2 . Arch Ophthalmol . 1990;108:328–329
  12. Good WV , Brodsky MC , Edwards MS , Hoyt WF . Bilateral retinal hamartomas in neurofibromatosis type 2 . Br J Ophthalmol . 1991;75:190
  13. Landau K , Yasargil GM . Ocular fundus in neurofibromatosis type 2 . Br J Ophthalmol . 1993;77:646–649
  14. Ragge NK , Baser ME , Riccardi VM , Falk RE . The ocular presentation of neurofibromatosis 2 . Eye . 1997;11(pt 1):12–18
  15. Dossetor FM , Landau K , Hoyt WF . Optic disk glioma in neurofibromatosis type 2 . Am J Ophthalmol . 1989;108:602–603
  16. Bosch MM , Wichmann W , Boltshauser E , Landau K . Optic nerve sheath meningiomas in patients with neurofibromatosis type 2 . Arch Ophthalmol . 2006;
  17. Baser ME , Friedman JM , Wallace AJ , Ramsden RT , Joe H , Evans DG . Evaluation of clinical diagnostic criteria for neurofibromatosis 2 . Neurology . 2002;59:1759–1765
  18. Sivalingam A , Augsburger J , Perilongo G , Zimmerman R , Barabas G . Combined hamartoma of the retina and retinal pigment epithelium in a patient with neurofibromatosis type 2 . J Pediatr Ophthalmol Strabismus . 1991;28:320–322
  19. Bouzas EA , Parry DM , Eldridge R , Kaiser-Kupfer MI . Familial occurrence of combined pigment epithelial and retinal hamartomas associated with neurofibromatosis 2 . Retina . 1992;12:103–107
  20. Ragge NK , Baser ME , Klein J , et al.   Ocular abnormalities in neurofibromatosis 2 . Am J Ophthalmol . 1995;120:634–641
  21. Meyers SM , Gutman FA , Kaye LD , Rothner AD . Retinal changes associated with neurofibromatosis 2 . Trans Am Ophthalmol Soc . 1995;93:245–252
  22. Wishart J . Case of tumors in the skull, dura mater, and brain . Edinburgh Med Surg J . 1822;393–397
  23. Cunliffe IA , Moffat DA , Hardy DG , Moore AT . Bilateral optic nerve sheath meningiomas in a patient with neurofibromatosis type 2 . Br J Ophthalmol . 1992;76:310–312
  24. Ragge NK . Clinical and genetic patterns of neurofibromatosis 1 and 2 . Br J Ophthalmol . 1993;77:662–672
  25. Mautner VF , Tatagiba M , Guthoff R , Samii M , Pulst SM . Neurofibromatosis 2 in the pediatric age group . Neurosurgery . 1993;33:92–96
  26. Tonsgard JH , Oesterle CS . The ophthalmologic presentation of NF-2 in childhood . J Pediatr Ophthalmol Strabismus . 1993;30:327–330
  27. Bouzas EA , Parry DM , Eldridge R , Kaiser-Kupfer MI . Visual impairment in patients with neurofibromatosis 2 . Neurology . 1993;43:622–623
  28. Rettele GA , Brodsky MC , Merin LM , Teo C , Glasier CM . Blindness, deafness, quadriparesis, and a retinal malformation (the ravages of neurofibromatosis 2) . Surv Ophthalmol . 1996;41:135–141
  29. Mautner VF , Hazim W , Pohlmann K , Berger R , Kluwe L , Haase W . Ophthalmologic spectrum of neurofibromatosis type 2 in childhood . Klin Monatsbl Augenheilkd . 1996;208:58–62
  30. MacCollin M , Mautner VF . The diagnosis and management of neurofibromatosis 2 in childhood . Semin Pediatr Neurol . 1998;5:243–252
  31. Harada T , Sawamura Y , Ohashi T , et al.   Severe optic disc edema without hydrocephalus in neurofibromatosis 2 . Jpn J Ophthalmol . 1998;42:381–384
  32. Yu CB , Lyons CJ , Dorrell ED , Taylor D . Congenital cavernous sinus syndrome in a child with neurofibromatosis type 2 . Can J Ophthalmol . 1999;34:101–103
  33. Bursztyn J , Rodriguez D . Importance of multidisciplinary consultations for children with neurofibromatosis . J Fr Ophthalmol . 1999;22:959–962
  34. Brodsky MC , Landau K , Wilson RS , Boltshauser E . Morning glory disc anomaly in neurofibromatosis type 2 . Arch Ophthalmol . 1999;117:839–841
  35. Tong JT , Bateman JB . Selective B-wave reduction with congenital cataract in neurofibromatosis-2 . Ophthalmology . 1999;106:1681–1683
  36. Thomas DA , Trobe JD , Cornblath WT . Visual loss secondary to increased intracranial pressure in neurofibromatosis type 2 . Arch Ophthalmol . 1999;117:1650–1653
  37. Lueder GT , Doll JT . Pseudopapilledema in neurofibromatosis type 2 . Am J Ophthalmol . 2000;129:405–407
  38. Onder F , Cosar CB , Akbatur H , Kural G . Bilateral retinal involvement as a presenting sign of neurofibromatosis 2 . J Pediatr Ophthalmol Strabismus . 2002;39:49–51
  39. Shields JA , Shields CL , Lavrich J . Melanocytoma of optic disk in a patient with neurofibromatosis 2 . Retina . 2002;22:222–223
  40. Bosch MM , Mironov A , Killer HE . Atypical manifestation of neurofibromatosis type 2 in a boy . Eye . 2005;19:705–706
  41. Kim JE , Ruttum MS . Neurofibromatosis type 2 in an infant presenting with visual impairment confirmed by genetic mutation analysis . Retina . 2005;25:938–940
  42. Evans DG , Birch JM , Ramsden RT . Paediatric presentation of type 2 neurofibromatosis . Arch Dis Child . 1999;81:496–499
  43. Pearson-Webb MA , Kaiser-Kupfer MI , Eldridge R . Eye findings in bilateral acoustic (central) neurofibromatosis (association with presenile lens opacities and cataracts but absence of Lisch nodules) . N Engl J Med . 1986;315:1553–1554
  44. Mautner VF , Lindenau M , Baser ME , et al.   The neuroimaging and clinical spectrum of neurofibromatosis 2 . Neurosurgery . 1996;38:880–885
  45. Gass J . Macular dysfunction caused by epiretinal membrane contraction . In: Stereoscopic atlas of macular diseases (diagnosis and treatment) . St Louis: CV Mosby; 1987;p. 694–712
  46. Wiestler OD , von Siebenthal K , Schmitt HP , Feiden W , Kleihues P . Distribution and immunoreactivity of cerebral micro-hamartomas in bilateral acoustic neurofibromatosis (neurofibromatosis 2) . Acta Neuropathol (Berl) . 1989;79:137–143
  47. Janse AJ , Tan WF , Majoie CB , Bijlsma EK . Neurofibromatosis type 2 diagnosed in the absence of vestibular schwannomas (a case report and guidelines for a screening protocol for children at risk) . Eur J Pediatr . 2001;160:439–443
  48. Perry A , Giannini C , Raghavan R , et al.   Aggressive phenotypic and genotypic features in pediatric and NF2-associated meningiomas (a clinicopathologic study of 53 cases) . J Neuropathol Exp Neurol . 2001;60:994–1003
  49. Baser ME , Kuramoto L , Joe H , et al.   Genotype-phenotype correlations for nervous system tumors in neurofibromatosis 2 (a population-based study) . Am J Hum Genet . 2004;75:231–239
  50. Kluwe L , Mautner V , Heinrich B , et al.   Molecular study of frequency of mosaicism in neurofibromatosis 2 patients with bilateral vestibular schwannomas . J Med Genet . 2003;40:109–114
  51. Nunes F , MacCollin M . Neurofibromatosis 2 in the pediatric population . J Child Neurol . 2003;18:718–724
  52. Jacoby LB , Jones D , Davis K , et al.   Molecular analysis of the NF2 tumor-suppressor gene in schwannomatosis . Am J Hum Genet . 1997;61:1293–1302
  53. Kluwe L , Mautner VF . Mosaicism in sporadic neurofibromatosis 2 patients . Hum Mol Genet . 1998;7:2051–2055
  54. Klein BE , Klein R , Linton KL . Prevalence of age-related lens opacities in a population (The Beaver Dam Eye Study) . Ophthalmology . 1992;99:546–552
  55. Egan RA , Lessell S . A contribution to the natural history of optic nerve sheath meningiomas . Arch Ophthalmol . 2002;120:1505–1508
  56. Landert M , Baumert BG , Bosch MM , Lutolf UM , Landau K . The visual impact of fractionated stereotactic conformal radiotherapy on seven eyes with optic nerve sheath meningiomas . J Neuroophthalmol . 2005;25:86–91
  57. Baser ME , Friedman JM , Aeschliman D , et al.   Predictors of the risk of mortality in neurofibromatosis 2 . Am J Hum Genet . 2002;71:715–723

PII: S0002-9394(06)00015-8

doi: 10.1016/j.ajo.2005.12.042

American Journal of Ophthalmology
Volume 141, Issue 6 , Pages 1068-1077.e2 , June 2006

Article Tools

* Image Usage & Resolution